» Articles » PMID: 29668719

Spatial Alterations of De Novo Purine Biosynthetic Enzymes by Akt-independent PDK1 Signaling Pathways

Overview
Journal PLoS One
Date 2018 Apr 19
PMID 29668719
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

A macromolecular complex of the enzymes involved in human de novo purine biosynthesis, the purinosome, has been shown to consist of a core assembly to regulate the metabolic activity of the pathway. However, it remains elusive whether the core assembly itself can be selectively controlled in the cytoplasm without promoting the purinosome. Here, we reveal that pharmacological inhibition of the cytoplasmic activity of 3-phosphoinositide-dependent protein kinase 1 (PDK1) selectively promotes the formation of the core assembly, but not the purinosome, in cancer cells. However, alternative signaling cascades that are associated with the plasma membrane-bound PDK1 activity, including Akt-mediated cascades, regulate neither the core assembly nor the purinosome in our conditions. Along with immunofluorescence microscopy and a knock-down study against PDK1 using small interfering RNAs, we reveal that cytoplasmic PDK1-associated signaling pathways regulate subcellular colocalization of three enzymes that form the core assembly of the purinosome in an Akt-independent manner. Collectively, this study reveals a new mode of compartmentalization of purine biosynthetic enzymes controlled by spatially resolved signaling pathways.

Citing Articles

Activation of the WNT4/ β-catenin/FOXO1 pathway by PDK1 promotes cervical cancer metastasis and EMT process.

Chen S, Zhang C, Huang H, Wang Y, Lian M, Hong G J Mol Histol. 2025; 56(1):68.

PMID: 39779500 DOI: 10.1007/s10735-024-10342-x.


A journey into the regulatory secrets of the purine nucleotide biosynthesis.

Ayoub N, Gedeon A, Munier-Lehmann H Front Pharmacol. 2024; 15:1329011.

PMID: 38444943 PMC: 10912719. DOI: 10.3389/fphar.2024.1329011.


Light-sensitive phosphorylation regulates retinal IMPDH1 activity and filament assembly.

Calise S, ONeill A, Burrell A, Dickinson M, Molfino J, Clarke C J Cell Biol. 2024; 223(4).

PMID: 38323936 PMC: 10849882. DOI: 10.1083/jcb.202310139.


The Purinosome: A Case Study for a Mammalian Metabolon.

Pedley A, Pareek V, Benkovic S Annu Rev Biochem. 2022; 91:89-106.

PMID: 35320684 PMC: 9531488. DOI: 10.1146/annurev-biochem-032620-105728.


From purines to purinergic signalling: molecular functions and human diseases.

Huang Z, Xie N, Illes P, Di Virgilio F, Ulrich H, Semyanov A Signal Transduct Target Ther. 2021; 6(1):162.

PMID: 33907179 PMC: 8079716. DOI: 10.1038/s41392-021-00553-z.


References
1.
Zhao H, Chiaro C, Zhang L, Smith P, Chan C, Pedley A . Quantitative analysis of purine nucleotides indicates that purinosomes increase de novo purine biosynthesis. J Biol Chem. 2015; 290(11):6705-13. PMC: 4358094. DOI: 10.1074/jbc.M114.628701. View

2.
Young L, Balin B, Weis M . Gö 6983: a fast acting protein kinase C inhibitor that attenuates myocardial ischemia/reperfusion injury. Cardiovasc Drug Rev. 2005; 23(3):255-72. DOI: 10.1111/j.1527-3466.2005.tb00170.x. View

3.
Najafov A, Sommer E, Axten J, DeYoung M, Alessi D . Characterization of GSK2334470, a novel and highly specific inhibitor of PDK1. Biochem J. 2010; 433(2):357-69. DOI: 10.1042/BJ20101732. View

4.
Biondi R, Kieloch A, Currie R, Deak M, Alessi D . The PIF-binding pocket in PDK1 is essential for activation of S6K and SGK, but not PKB. EMBO J. 2001; 20(16):4380-90. PMC: 125563. DOI: 10.1093/emboj/20.16.4380. View

5.
An S, Deng Y, Tomsho J, Kyoung M, Benkovic S . Microtubule-assisted mechanism for functional metabolic macromolecular complex formation. Proc Natl Acad Sci U S A. 2010; 107(29):12872-6. PMC: 2919939. DOI: 10.1073/pnas.1008451107. View